In 2023, the share of corresponding/leading authors in scientific publications in the UK for Immunology and Allergy stood at 83.6%. The forecast data from 2024 to 2028 suggests a gradual decline, with values dropping from 83.2% in 2024 to 81.67% in 2028. Year-on-year, the decrease in share ranges from about 0.47% to 0.48%. The compound annual growth rate (CAGR) over these five years is approximately -0.47%, indicating a consistent decrease in the share of corresponding/leading authors in this domain.
Future trends to watch include the potential impact of collaborative research initiatives, increased diversity in authorship, and the influence of open-access journals, which might further shift authorship dynamics in UK scientific publications within Immunology and Allergy.
